KORINNE MURCEK: Open Payments
NPI 1154585495 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,428 in 62 payments from 32 companies in 2025. Trend: 2023 $969 · 2024 $706 · 2025 $1,428
Food & beverage: $1,338Education: $90
| Company | Payments | Amount |
|---|---|---|
| Octapharma USA, Inc. | 1 | $240 |
| PFIZER INC. | 10 | $139 |
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| ABBVIE INC. | 3 | $73 |
| TerSera Therapeutics LLC | 2 | $66 |
| Janssen Biotech, Inc. | 4 | $60 |
| Celgene Corporation | 3 | $48 |
| Kite Pharma, Inc. | 2 | $43 |
| BeOne Medicines USA, Inc. | 2 | $41 |
Products named: OCTAGAM IMMUNE GLOBULIN (HUMAN), SARCLISA, IBRANCE, OPDUALAG, REBLOZYL, VENCLEXTA, OPDIVO, Yescarta.
Industry payments across NE — which companies pay providers there.
